Radiofrequency Denervation and Brain Imaging
RecruitingNCT05641948
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this observational study is to learn about changes in brain and its activity of following radiofrequency denervation treatment for chronic low back pain. The main question it aims to answer are: * report the magnitude of the brain changes following radiofrequency treatment for low back pain. * identify changes unique to radiofrequency treatment Patients with nociceptive type low back pain of moderate to severe intensity will be identified to undergo radiofrequency treatment. They will have 3 MRI scans - Baseline, after the diagnostic injections and 3 months after radiofrequency treatment. They will also fill questions relating to their pain, disability and health related quality of life.
Study details
- Official title
- Radiofrequency Denervation and Brain Structure, Function And Connectivity In Chronic Low Back Pain Patients
- Conditions
- Interventions
- Other: MRI scan
- Sponsor
- University of Aberdeen
- Collaborators
- NHS Grampian
- Start date
- 2023-04-03
- Primary completion
- 2026-04-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United Kingdom
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18 years or older * Chronic moderate to severe cLBP (defined by average pain intensity of ≥ 4 in the 11 point Numerical Pain rating scale and a minimum duration of 1 year) * Identified by clinical team as suitable for RFD pathway * Predominantly nociceptive pain (as defined by PainDetect score ≤12) * Stable on current analgesic regime * Able to communicate in English * Has the capacity to and agrees to give informed consent for participation in the study * Positive response to a single diagnostic MBB with 1 ml or less of local anaesthetic (bupivacaine 0.5%) at each level. (a positive response is defined as ≥80% pain relief at 3 hours, based on patient reported assessment) Exclusion Criteria: * Any patient whose physical condition will preclude them from lying still for the duration of the brain scan. * Contraindication to magnetic resonance scanning such as an implantable cardiac device. * Women who are, or may be, pregnant. (Pregnant patients do not undergo pain procedures under radiological guidance as per routine clinical care) * Significant anxiety and depression (as defined by HADS score ≥ 9) * Clinical suspicion that alternative diagnosis is the reason for LBP * Presence of chronic primary pain conditions (Fibromyalgia, chronic widespread pain, Complex Regional Pain Syndrome, Chronic Primary Headache, Orofacial pain, Chronic primary visceral pian and Chronic Primary musculoskeletal pain as defined by ICD-11 classification) * Presence of thoracic or neck pain * History of previous RF denervation * Regular use of two or more dependence forming drugs (opioids, gabapentinoids, Benzodiazepines, tricyclics antidepressants and z-drugs)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05641948